Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions by Merve Hazal Ser, Mason J. Webb, Ugur Sener

Get full text

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma by Mason J. Webb, Ugur Sener, Richard G. Vile

Get full text

The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma by Bryan J. Neth, Mason J. Webb, Ian F. Parney, Ugur T. Sener

Get full text

Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report by Mason J Webb, William G Breen, Nadia N Laack, Konstantinos Leventakos, Jian L Campian, Ugur Sener

Get full text

Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic viruses by Mason J. Webb, Timothy Kottke, Benjamin L. Kendall, Jack Swanson, Chisom Uzendu, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Mitesh Borad, Lewis Roberts, Rosa M. Diaz, Michael Olin, Antonella Borgatti, Richard Vile

Get full text

Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response by Mason J. Webb, Thanich Sangsuwannukul, Jacob van Vloten, Laura Evgin, Benjamin Kendall, Jason Tonne, Jill Thompson, Muriel Metko, Madelyn Moore, Maria P. Chiriboga Yerovi, Michael Olin, Antonella Borgatti, Mark McNiven, Satdarshan P. S. Monga, Mitesh J. Borad, Alan Melcher, Lewis R. Roberts, Richard Vile

Get full text